Trichloroethylene Exposure and Parkinson's Disease: Environmental Risk, Metabolic Pathways, and Mechanistic Insights.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and observational literature
PubMed 40614023 · doi:10.1007/s12035-025-05172-1
What was done
This review synthesized published literature regarding the environmental distribution, human exposure routes, and metabolic fate (via cytochrome P450 oxidation and glutathione conjugation) of the industrial solvent trichloroethylene (TCE), evaluating mechanistic and epidemiological links to Parkinson's disease (PD).
What was found
The abstract reports qualitative mechanistic findings and provides no quantitative metrics or effect sizes. It details that reactive TCE metabolites inhibit mitochondrial complex I, generate oxidative stress, activate neuroinflammatory cascades, and induce α-synuclein aggregation, contributing to the selective degeneration of dopaminergic neurons in the substantia nigra.
Why it matters
It consolidates mechanistic pathways linking a pervasive environmental pollutant to Parkinson's disease pathogenesis, supporting toxicant exposure as a contributor to dopaminergic neurodegeneration.
Limits
As presented in the abstract, no primary human or animal data are reported, no systematic search criteria or study counts are specified, and no quantitative meta-analysis is performed. Accurately quantifying chronic, low-level human TCE exposure remains a significant methodological barrier.
Cited by
- supports Trichloroethylene (TCE) is an industrial cleaner and dry-cleaning solvent that contaminates groundwater, targets mitochondria, and is associated with the development of Parkinson's disease.